Mesenchymal stem cells: clinical applications and biological characterization.

By Frank Barry, J. Murphy. International Journal of Biochemistry and Cell Biology, 2004

1,743 citations recorded by the source corpus.

Subfields: Biomaterials, Genetics, Surgery

View Paper: https://www.semanticscholar.org/paper/b0356902ef7a714cc45076dafdaf4c75cb097641

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomaterials

In Genetics

In Surgery

Citations in the corpus

Engineering Complex Tissues (2006, positive): “However, MPCs after expansion and seeding into a scaffold are able to differentiate toward chondrocytes under the appropriate culture conditions, but whether they can generate tissue with the two zones is not known.(129,130) The biphasic (osteochondral-type) constructs can be created in a shape indi”
Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. (2008, background): “Bone marrowderived MSCs have been shown to differentiate into several different types of tissues, such as cartilage, bone, muscle, and adipose tissue ( Barry and Murphy, 2004; Le Blanc and Ringden, 2006).”
Same or Not the Same? Comparison of Adipose Tissue-Derived Versus Bone Marrow-Derived Mesenchymal Stem and Stromal Cells (2012, neutral): “Since MSCs can be easily isolated from bone marrow and other sources, it was originally thought that after the delivery of cultureexpanded MSCs to the injured host, they would migrate to the site of injury and directly differentiate into the cells of an appropriate phenotype and function, thus contr”
Mesenchymal stem cells avoid allogeneic rejection (2005, background): “These cells, first characterized by Friedenstein and colleagues more than thirty years ago, are multipotent cells capable of differentiating into several lineages including; cartilage, bone, muscle, tendon, ligament and adipose tissue[2,5,6].”
Adipose-derived stem cells differentiate into a Schwann cell phenotype and promote neurite outgrowth in vitro. (2007, background): “There is also some evidence that MSC may be non-immunogenic or hypo-immunogenic (Barry and Murphy, 2004).”
Cartilage homeostasis in health and rheumatic diseases (2009, background): “cartilage progenitor cells for cartilage tissue engineering [203-206].”
Stem cell-based tissue engineering with silk biomaterials. (2006, background): “These cells also have the potential for a wide range of therapeutic applications through autologous, allogeneic or xenogeneic stem cell transplantation [132,133].”